Virafin from Zydus Cadila priced at Rs 11,995 per dose
The company has commenced dispatching the drug which can reportedly reduce oxygen support in COVID-19 patients, as per reports
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pegylated Interferon alpha-2b
Zydus Cadila gets EUA from DCGI for hepatitis drug Virafin to treat COVID-19
When administered early on during COVID, Virafin will help patients recover faster and avoid much of the complications, informed…
Zydus seeks DCGI nod for Pegylated Interferon alpha-2b to treat COVID-19
91.15 per cent of patients treated with PegIFN were RT PCR negative by day 7 as compared to 78.90 per cent on the standard of care…
Zydus gets DCGI approval to commence Phase III clinical trials with Pegylated Interferon alpha-2b
In Phase II clinical trials, Pegylated Interferon alpha – 2b increased viral reduction and reduced the need for supplemental…
Zydus concludes Phase II trials of Pegylated Interferon alpha-2b for COVID-19, to begin Phase III…
In 19 out of 20 patients, a single 1 mcg/kg dose of the drug demonstrated viral clearance as assessed by RT-PCR and a significant…
Zydus receives approval from COFEPRIS to conduct clinical trials for COVID-19 treatment therapy
Zydus had earlier approached the DCGI to investigate the role of Pegylated Interferon alpha-2b for COVID 19 and the clinical…